Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivo | Zendy

Tetsufumi Koga | Zendy; Takashi Fukuoka | Zendy; Norio Doi | Zendy; Tamako Harasaki | Zendy; Harumi Inoue | Zendy; Hitoshi Hotoda | Zendy; Masayo Kakuta | Zendy; Yasunori Muramatsu | Zendy; Naotoshi Yamamura | Zendy; Misa Hoshi | Zendy; Takashi Hirota | Zendy

Open Access

Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivo

Author(s) -

Tetsufumi Koga,

Takashi Fukuoka,

Norio Doi,

Tamako Harasaki,

Harumi Inoue,

Hitoshi Hotoda,

Masayo Kakuta,

Yasunori Muramatsu,

Naotoshi Yamamura,

Misa Hoshi,

Takashi Hirota

Publication year - 2004

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkh417

Subject(s) - antimycobacterial , microbiology and biotechnology , mycobacterium tuberculosis , mycobacterium , tuberculosis , in vivo , broth microdilution , biology , nontuberculous mycobacteria , rifabutin , in vitro , medicine , antibiotics , minimum inhibitory concentration , clarithromycin , pathology , biochemistry

The antimycobacterial activities of RS-112997, RS-124922 and RS-118641, three capuramycin analogues that inhibit phospho-N-acetylmuramyl-pentapeptide translocase, were tested against clinical isolates of Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research